heparin
In this study, we characterized the kinetics of hemostatic       abnormalities induced by acute ischemic stroke and its thrombolytic (recombinant        tissue plasminogen activator [rtPA]) or anticoagulant (heparin) treatment.
In this study, we characterized the kinetics of hemostatic       abnormalities induced by acute ischemic stroke and its thrombolytic (recombinant        tissue plasminogen activator [rtPA]) or  @OBJECT$  @PREDICAT$  @SUBJECT$ ) treatment.